Drugs modulating the L-arginine:NO:cGMP pathway – current use in therapy

Journal Title: Current Issues in Pharmacy and Medical Sciences - Year 2016, Vol 29, Issue 1

Abstract

Nitric oxide (NO) is a relatively novel messenger that plays a significant role in a wide range of physiological processes. Currently, it is known that, both, lack and excess of NO can cause diseases, thus a lot of substances have been discovered and utilized which can change the concentration of this molecule within the organism. The aim of the present work is to provide an overview of currently used agents modulating the L-arginine:NO:cGMP pathway, as well as to summarize current understanding of their pharmacological profiles. Nowadays, most of these agents are employed particularly in the treatment of cardiovascular diseases. Further studies can hold promise for enhancing the therapeutic equipment for a variety of other impairments, such as osteoporosis, and also in treatments of the central nervous system.

Authors and Affiliations

Magdalena Polakowska, Jolanta Orzelska-Górka, Sylwia Talarek

Keywords

Related Articles

Formulation and evaluation of sulfadimidine and trimethoprim tablets using wet granulation technique

The objective of this study was to develop tablet formulations of sulphadimidine sodium (SDD-Na) and trimethoprim (TMP), evaluate and compare the efficiency of some excipients such as: superdisintegrant - croscarmellose...

Dissolution testing of tablets within and beyond expiration date with olanzapine as pharmaceutical ingredient

The expiration date is a guarantee from the manufacturer that a drug product will remain chemically stable - and thus maintain its full potency and safety - prior to that date. Authors of this study have checked whether...

Influence of the dissolution medium type on the release of diclofenac sodium and papaverine hydrochloride from granules and tablets

The release studies of diclofenac sodium (DIC) and papaverine hydrochloride (PAP) from composed granules and tablets into the dissolution media at different pH using the flow-through cell apparatus were carried out. The...

The survival of dental implants with different implant-abutment connection systems

The aim of the study was to evaluate the survival of implants with different implant-abutment connection systems, in patients who had two kinds of implants implanted. In total, 240 implants were implanted – 91 implants w...

Download PDF file
  • EP ID EP138850
  • DOI 10.1515/cipms-2016-0004
  • Views 116
  • Downloads 0

How To Cite

Magdalena Polakowska, Jolanta Orzelska-Górka, Sylwia Talarek (2016). Drugs modulating the L-arginine:NO:cGMP pathway – current use in therapy. Current Issues in Pharmacy and Medical Sciences, 29(1), 14-21. https://europub.co.uk/articles/-A-138850